Skip to content

Brown adipose tissue activity and thyroid hormone

Brown adipose tissue activity and thyroid hormone - Brown adipose tissue activity and thyroid hormone

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37371
Enrollment
18
Registered
2012-03-07
Start date
2012-04-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brown adipose tissue thyroid carcinoma

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Male or postmenopausal females undergoing a total thyroidectomy for well-differentiated thyroid carcinoma - Age 18-65 years - Stable physical activity levels for at least six months - Note: In case of use of anticoagulation, the dose will be adjusted according to plasma thyroid hormone values.

Exclusion criteria

Exclusion criteria: - Psychological unstable subjects (as judged by the treating medical specialist) - Subjects with mental retardation (as judged by the treating medical specialist) - Subjects with severe behavior disorders (as judged by the treating medical specialist) - Pregnant subjects - The use of the following medication is an exclusion criterium; o ß-blockers - Participation in an intensive weight-loss program or vigorous exercise program during the last year before the start of the study - Abuse of drugs and/or alcohol - Severe diabetes which requires application of insulin or patients with diabetes-related complications - Patients that have donated blood in the past 6 months

Design outcomes

Primary

MeasureTime frame
The main endpoint of this study is the effect of thyroid hormone and thyroid-stimulating hormone on BAT activity in kBq and SUV.

Secondary

MeasureTime frame
Secondary endpoints are the effects of thyroid hormone and thyroid-stimulating hormone on energy metabolism, body composotion, plasma values of thyroid hormone, body core temperature, skin surface temperature and skin perfusion.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)